| Order book | Strong order book mentioned for NSE listing period. |
|---|---|
| Demand visibility | Expanding through population-scale screening initiatives. |
| Management confidence | High |
Growth
No specific revenue or profit growth figures for Q1 FY27 are provided in the presentation.
Outlook
Focus on Made-in-India MRI production (2025), scaling AI screening pathways (MIDAS), and global expansion in MENA and SEA.
Risks
Market fluctuations, regulatory changes, technology cycles, and reliance on partner clinical validations.
Last quarter's promises, checked
Delivered
- Revenue split 70% India/30% export in H1 FY26 → Delivered 120% YoY growth with 30% export share (= BEAT)
- H1 FY26 PAT growth improvement → Delivered 107x YoY increase to INR 38 crores (= BEAT)
- Domestic MRI manufacturing launch → First accredited Make-in-India MRI system established (= BEAT)
Partly delivered
- Nanomedic CDSCO approval by end of Nov 2025 → Pending approval, awaiting final certification for MD 26/27 (= PARTIAL)
Investor Presentation filed with NSE, NSE: FISCHER. Summary written with AI assistance from the document.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹34.29
- Market cap
- ₹2,375 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 79.7×Sector 37.5×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 5.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Annual Report
The company issued a corrigendum to its FY 2025-26 Annual Report. This update corrects financial highlights, auditor report details, and capital management tables.
Fischer Medical Ventures Acquisition Worth ₹49.88 Cr
Fischer Medical Ventures will invest ₹49.88 Crore into its three material wholly-owned subsidiaries via rights issues to support capital expansion.
- Value
- ₹49.88 Cr
Fischer Medical Ventures Business Update
Fischer Medical Ventures published a Chairman's Letter outlining its Radiology, Preventive Healthcare and Wellness segments plus Indonesia and Philippines deployments. No new transaction, order or capital event is announced.
Fischer Medical Ventures Annual Report
Fischer Medical Ventures Limited has submitted its Annual Report for the financial year 2025-2026 as per SEBI regulations. The document is available on the company website.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited has scheduled its 33rd Annual General Meeting on September 29, 2026, through video conferencing. The company also announced the e-voting and book closure dates.
Fischer Medical Ventures Investor Presentation: Key Takeaways
Fischer Medical Ventures (FMV) presentation outlines a vertically integrated AI healthcare ecosystem spanning medical imaging, screening, and hospital digitization through subsidiaries like Time Medical and FlynnCare.